We recently reported that chronic administration of berberine can significantly reduce Aβ pathology, gliosis and cognitive impairments in TgCRND8 mice via reducing the level of C-terminal fragments of APP and the level of phosphorylated APP [15]. The gene discussed is APP; the disease is Cognitive impairment.